Paliperidone Palmitate



Indications and Reactions:

Role Indications Reactions
Primary
Schizophrenia 47.5%
Anxiety 6.7%
Insomnia 6.4%
Schizoaffective Disorder 4.6%
Prophylaxis 4.5%
Schizophrenia, Paranoid Type 4.3%
Product Used For Unknown Indication 3.8%
Depression 3.4%
Atopy 2.6%
Gastritis 2.5%
Psychotic Disorder 1.8%
Agitation 1.7%
Hypertension 1.4%
Constipation 1.3%
Drug Abuse 1.3%
Drug Therapy 1.3%
Sleep Disorder 1.3%
Drug Use For Unknown Indication 1.2%
Sedation 1.2%
Tension 1.2%
Schizophrenia 27.8%
Psychotic Disorder 20.6%
Suicidal Ideation 9.4%
Suicide Attempt 7.2%
Anxiety 6.1%
Depression 3.9%
Aspartate Aminotransferase Increased 3.3%
Delirium 2.2%
Intentional Self-injury 2.2%
Schizophrenia, Paranoid Type 2.2%
Tremor 2.2%
Deep Vein Thrombosis 1.7%
Delusion 1.7%
Depression Suicidal 1.7%
Vomiting 1.7%
Weight Increased 1.7%
Acute Psychosis 1.1%
Completed Suicide 1.1%
Contusion 1.1%
Dyspnoea 1.1%
Secondary
Schizophrenia 46.4%
Anxiety 7.0%
Insomnia 5.8%
Schizophrenia, Paranoid Type 5.1%
Schizoaffective Disorder 5.0%
Lower Limb Fracture 4.0%
Product Used For Unknown Indication 3.3%
Constipation 3.0%
Depression 2.9%
Psychotic Disorder 2.8%
Cellulitis 2.0%
Agitation 1.8%
Atopy 1.7%
Gastritis 1.7%
Irritability 1.5%
Wheezing 1.5%
Hypertension 1.3%
Drug Therapy 1.1%
Sleep Disorder 1.0%
Suicide Attempt 1.0%
Schizophrenia 30.5%
Psychotic Disorder 18.1%
Suicidal Ideation 10.6%
Suicide Attempt 4.9%
Depression 4.4%
Anxiety 4.0%
Acute Psychosis 3.1%
Psychiatric Symptom 3.1%
Vomiting 3.1%
Aggression 2.7%
Restlessness 1.8%
Syncope 1.8%
Tension 1.8%
Tremor 1.8%
Weight Increased 1.8%
Deep Vein Thrombosis 1.3%
Depression Suicidal 1.3%
Dyskinesia 1.3%
Haematemesis 1.3%
Inappropriate Schedule Of Drug Administration 1.3%
Concomitant
Schizophrenia, Disorganised Type 23.5%
Product Used For Unknown Indication 17.6%
Schizoid Personality Disorder 15.7%
Bipolar Disorder 9.8%
Schizoaffective Disorder 7.8%
Abdominal Discomfort 3.9%
Anxiety 3.9%
Off Label Use 3.9%
Osteopenia 3.9%
Schizophrenia, Paranoid Type 3.9%
Drug Use For Unknown Indication 2.0%
Narcolepsy 2.0%
Schizophrenia 2.0%
Suicidal Ideation 31.6%
Pruritus 21.1%
Thinking Abnormal 10.5%
Weight Decreased 10.5%
Psychotic Disorder 5.3%
Pulmonary Embolism 5.3%
Thrombocytopenia 5.3%
White Blood Cell Count Abnormal 5.3%
White Blood Cell Count Decreased 5.3%
Interacting
Product Used For Unknown Indication 100.0%
Hyperprolactinaemia 100.0%